Syndax Pharmaceuticals Inc. is a biopharmaceutical company that focuses on developing targeted therapies for cancer and other diseases. With a strong pipeline, innovative technology, and a commitment to improving patient outcomes, Syndax is poised to make a significant impact in the field of oncology.
